North America to Dominate Restriction Endonuclease Market until 2025

Increasing funding in genomics and life science along with surging geriatric populations to drive the growth of global restriction endonuclease market

According to TechSci Research report, “Global Restriction Endonuclease Market By Type (I, II, III, IV), By Application (Genetic Engineering, DNA Mapping, Gene Sequencing and Others), By End Type (Sticky End, Blunt End), By Source (Bacteria, Archaea), By Cleavage Specificity (Isoschizomers, Neoschizomers), By End-User (Pharmaceutical and Biotechnology Companies, Academic Research Institutes and Others), By Region,  Competition, Forecast & Opportunities, 2025”, global restriction endonuclease market is expected to grow an impressive CAGR over the forecast period. Rapid rising funding in genomics and life science is one of the major factor accounting for the growth of global restriction endonuclease market. Moreover, number of geriatric populations is increasing at an alarming rate which is further expected to bode well for the growth of global restriction endonuclease through the forecast years. In addition to this, new advanced techniques are evolved such as DNA sequencing and gene expression, which in turn is positively influencing the growth of global restriction endonuclease market. Also, growing use of these restriction endonucleases in various applications such as in vivo gene editing, building DNA libraries, among others is making headway for the growth of global restriction endonuclease market over the coming years. However, there are some factors such as high cost required for the production of restriction endonuclease and level of unreliability of these enzymes that can act as major impediments to the growth of global restriction endonuclease market through 2025.

Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on“Global Restriction Endonuclease Market “

https://www.techsciresearch.com/report/restriction-endonuclease-market/4638.html

Global restriction endonuclease market can be segmented based on type, application, end type, source, cleavage, end-user, company and region. Considering the end-user, the market is fragmented into pharmaceutical and biotechnology companies, academic research institutes and others. The pharmaceutical and biotechnology companies segment dominated the global restriction endonuclease market in terms of largest market size until 2019 and is further anticipated to maintain its dominance during the forecast period as well which can be accredited to growing utilization of restriction endonuclease to map DNA and to cut and splice it for use in genetic engineering. Additionally, it helps in diagnosis of hereditary diseases and detects various infectious diseases which is further aiding the growth of the segment. In terms of application, the market is fragmented into genetic engineering, DNA mapping, gene sequencing and others. Out of which, the genetic engineering application segment is projected to grow at a high pace during the forecast period which can be accredited to its use to produce recombinant DNAs.

New England Biolabs, Thermo Fisher Scientific, Takara Bio, Sigma-Aldrich, Illumina, Agilent Technologies, Promega, Jena Biosciences, Genetix Biotech Asia Pvt. Ltd., Roche, Merck, Pfizer, Amgen, Vertex Pharmaceuticals, BioMarin Pharmaceutical, PerkinElmer, Abcam, Abbexa, Sisco Research Laboratories Pvt Ltd, Nippon Gene are among others are the leading players operating in global restriction endonuclease market. The leading players are adopting several growth strategies to enhance the market scenario of restriction endonuclease. Other competitive strategies include mergers & acquisitions to diverse their product portfolio in order to strengthen their market position.

Download sample report @ https://www.techsciresearch.com/sample-report.aspx?cid=4638  

customers can also request for 10% free customization on this report.

“North America is forecast to dominate the global restriction endonuclease market during the next five years on account of presence of strong research and development in biotechnology in the region. Moreover, rising contract research outsourcing coupled with increasing research in the fields of life science is also contributing to the growing trend. Furthermore, Asia-Pacific region is anticipated to register high growth through 2025 due to continuously developing healthcare infrastructure and rising patient awareness. Moreover, beneficial government initiatives are further boosting the market growth in the region.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“Global Restriction Endonuclease Market By Type (I, II, III, IV), By Application (Genetic Engineering, DNA Mapping, Gene Sequencing and Others), By End Type (Sticky End, Blunt End), By Source (Bacteria, Archaea), By Cleavage Specificity (Isoschizomers, Neoschizomers), By End-User (Pharmaceutical and Biotechnology Companies, Academic Research Institutes and Others), By Region, Competition, Forecast & Opportunities, 2025” has evaluated the future growth potential of global restriction endonuclease market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global restriction endonuclease market.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]